LCN2 and metabolic dysfunction-associated steatotic liver disease: The action of LCN-2 is complex, on the one hand LCN-2 is upregulated in cases of insulin resistance such as obesity and diabetes and on other hand LCN-2 has a protective effect on NAFLD.